LPS-Induced Epithelial-Mesenchymal Transition of Intrahepatic Biliary Epithelial Cells


      Recent studies have revealed that the epithelial-mesenchymal transition (EMT) of bile duct epithelial cells is engaged in hepatic fibrogenesis. However, the association between etiological factors of liver disease such as virus or bacterial infection and EMT remains to be investigated. The present study focuses on the inductive role of endotoxin, the main component of the cell wall's ectoblast of gram-negative bacteria, in the EMT of human intrahepatic biliary epithelial cells (HIBEpiCs).


      The expressions of E-cadherin, S100A4, α-SMA, TGF-β1, and Smad2/3 in HIBEpiCs cultured with or without lipopolysaccharide LPS, were detected by real-time PCR and Western blotting. We blocked the expression of TGF-β1 using paclitaxel and knocked down Smad2/3 by siRNA to explore the role of TGF-β1/Smad2/3 pathway in the EMT of HIBEpiCs.


      Resting HIBEpiCs showed epithelioid cobblestone morphology, and underwent a phenotypic change to produce bipolar cells with a fibroblastic morphology when co-cultured with LPS. After LPS stimulation and the up-regulation of mRNA and protein expression of TGF-β1 and Smad2/Smad3, the mRNA and protein expression of mesenchymal markers (S100A and α-SMA) increased significantly. Paclitaxel inhibited the mRNA and protein expression of TGF-β1 in vitro. Knock-down of Smad2/3 by siRNA led to up-regulation of epithelial markers E-cadherin and down-regulation of S100A and α-SMA, indicating a reversal of the EMT.


      LPS can induce the expression of TGF-ß1 and a subsequent EMT in HIBEpiCs, and the inhibition of TGF-ß1 or Smad 2/3 could reverse this EMT, suggesting that LPS may play a potential role in the EMT of HIBEpiCs.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Surgical Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Ramadori G.
        • Saile B.
        Portal tract fibrogenesis in the liver.
        Lab Invest. 2004; 84: 153
        • Xia J.L.
        • Dai C.
        • Michalopoulos G.K.
        • et al.
        Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation.
        Am J Pathol. 2006; 168: 1500
        • Sato Y.
        • Harada K.
        • Ozaki S.
        • et al.
        Cholangiocytes with mesenchymal features contribute to progressive hepatic fibrosis of the polycystic kidney rat.
        Am J Pathol. 2007; 171: 1859
        • Rygiel K.A.
        • Robertson H.
        • Marshall H.L.
        • et al.
        Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease.
        Lab Invest. 2008; 88: 112
        • Omenetti A.
        • Porrello A.
        • Jung Y.
        • et al.
        Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans.
        J Clin Invest. 2008; 118: 3331
        • Zavadil J.
        • Bottinger E.P.
        TGF-β and epithelial-to-mesenchymal transitions.
        Oncogene. 2005; 24: 5764
        • Liu Y.
        Epithelial to mesenchymal transition in renal fibrogenesis: Pathologic significance, molecular mechanism, and therapeutic intervention.
        J Am Soc Nephrol. 2004; 15: 1
        • Choi H.S.
        • Savard C.E.
        • Choi J.W.
        • et al.
        Paclitaxel interrupts TGF-β 1 signaling between gallbladder epithelial cells and myofibroblasts.
        J Surg Res. 2007; 141: 183
        • Gressner A.M.
        • Weiskirchen R.
        Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets.
        J Cell Mol Med. 2006; 10: 76
        • Schiffer M.
        • von Gersdorff G.
        • Bitzer M.
        • et al.
        Smad proteins and transforming growth factor-β signaling.
        Kidney Int Suppl. 2000; 77: S45
        • ten Dijke P.
        • Hill C.S.
        New insights into TGF-β-Smad signalling.
        Trends Biochem Sci. 2004; 29: 265
        • Yu H.T.
        Progression of chronic renal failure.
        Arch Intern Med. 2003; 163: 1417
        • Zeisberg M.
        • Hanai J.
        • Sugimoto H.
        • et al.
        BMP-7 counteracts TGF-β1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.
        Nat Med. 2003; 9: 964
        • Robertson H.
        • Ali S.
        • McDonnell B.J.
        • et al.
        Chronic renal allograft dysfunction: The role of T cell-mediated tubular epithelial to mesenchymal cell transition.
        J Am Soc Nephrol. 2004; 15: 390
        • Tyler J.R.
        • Robertson H.
        • Booth T.A.
        • et al.
        Chronic allograft nephropathy: Intraepithelial signals generated by transforming growth factor-β and bone morphogenetic protein-7.
        Am J Transplant. 2006; 6: 1367
        • Robertson H.
        • Kirby J.A.
        • Yip W.W.
        • et al.
        Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis.
        Hepatology. 2007; 45: 977